Literature DB >> 1407568

The epidemiology of myasthenia gravis in central and western Virginia.

L H Phillips1, J C Torner, M S Anderson, G M Cox.   

Abstract

We conducted a study of the epidemiology of myasthenia gravis (MG) in four locations in central and western Virginia from 1970 through 1984. The population surveyed was 555,851 in 1984. A total of 73 new cases of MG occurred during the survey period, producing an overall average annual incidence rate of 9.1 per million. The point prevalence rate in 1980 was 13.4 per 100,000, and in 1984 it was 14.2. Approximately 15% of the population was black, and we found that incidence and prevalence rates for the black population were higher than the corresponding white population. When the population was subdivided into <50 and 50+ age groups, the incidence and prevalence were significantly higher in the older group. The rates we report here are higher than rates reported from any other locality. The reasons for the higher rates include optimal case identification, survey of a population with a higher incidence, and increasing aging of the population.

Entities:  

Mesh:

Year:  1992        PMID: 1407568     DOI: 10.1212/wnl.42.10.1888

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

1.  Nationwide population-based epidemiological study of myasthenia gravis in taiwan.

Authors:  Chien-Hsu Lai; Hung-Fu Tseng
Journal:  Neuroepidemiology       Date:  2010-06-03       Impact factor: 3.282

2.  Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trial.

Authors:  Michael Benatar; Michael P Mcdermott; Donald B Sanders; Gil I Wolfe; Richard J Barohn; Richard J Nowak; Michael Hehir; Vern Juel; Hans Katzberg; Rabi Tawil
Journal:  Muscle Nerve       Date:  2016-01-27       Impact factor: 3.217

Review 3.  Thymectomy for myasthenia gravis.

Authors:  J D Urschel; R P Grewal
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

4.  Strabismus surgery and long-term visual outcomes in patients with preadolescent onset ocular myasthenia gravis.

Authors:  Jinu Han; So Young Han; Sueng-Han Han; Jong Bok Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-16       Impact factor: 3.117

5.  Myasthenia gravis: a changing pattern of incidence.

Authors:  I Casetta; E Groppo; R De Gennaro; E Cesnik; L Piccolo; S Volpato; E Granieri
Journal:  J Neurol       Date:  2010-07-11       Impact factor: 4.849

6.  Characteristics of late-onset myasthenia gravis.

Authors:  Saša A Zivković; Paula R Clemens; David Lacomis
Journal:  J Neurol       Date:  2012-04-05       Impact factor: 4.849

7.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

Review 8.  Thymic malignancies: from clinical management to targeted therapies.

Authors:  Ronan J Kelly; Iacopo Petrini; Arun Rajan; Yisong Wang; Giuseppe Giaccone
Journal:  J Clin Oncol       Date:  2011-11-21       Impact factor: 44.544

9.  The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.

Authors:  Inmaculada B Aban; Gil I Wolfe; Gary R Cutter; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Robin Conwit; John Newsom-Davis
Journal:  J Neuroimmunol       Date:  2008-09-15       Impact factor: 3.478

10.  Myasthenia gravis: a population based epidemiological study in Cambridgeshire, England.

Authors:  N P Robertson; J Deans; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.